Role of pRB dephosphorylation in cell cycle regulation.
暂无分享,去创建一个
E. Rubin | S. Tamrakar | J. Ludlow | S Tamrakar | E Rubin | J W Ludlow | John W. Ludlow | Ethel Rubin
[1] A. Pichler,et al. A binding site for transcription factor E2F is a target for trans activation of murine thymidine kinase by polyomavirus large T antigen and plays an important role in growth regulation of the gene , 1993, Journal of virology.
[2] L. Chin,et al. Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.
[3] J. Nevins,et al. Regulation of the cyclin E gene by transcription factor E2F1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[4] J. LaBaer,et al. New functional activities for the p21 family of CDK inhibitors. , 1997, Genes & development.
[5] R. Roeder,et al. Isolation and partial characterization of the multiple forms of deoxyribonucleic acid-dependent ribonucleic acid polymerase in the mouse myeloma, MOPC 315. , 1974, The Journal of biological chemistry.
[6] Chun-Ming Huang,et al. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family , 1989, Cell.
[7] E. Rubin,et al. Protein Phosphatase Type 1, The Product of the Retinoblastoma Susceptibility Gene, And Cell Cycle Control , 1998 .
[8] Lingyun Zhu,et al. Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins , 1995, Molecular and cellular biology.
[9] M. Serrano,et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma , 1995, Science.
[10] A. Simeone,et al. Activation of major histocompatibility complex class I mRNA containing an Alu-like repeat in polyoma virus-transformed rat cells , 1985, Nature.
[11] R. Weinberg,et al. Growth suppression by p16ink4 requires functional retinoblastoma protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[12] S. Pajovic,et al. Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins , 1997, Molecular and cellular biology.
[13] Tony Kouzarides,et al. Retinoblastoma protein recruits histone deacetylase to repress transcription , 1998, Nature.
[14] D. Nelson,et al. Characterization of the mitotic phase pRb-directed protein phosphatase activity , 1997, Oncogene.
[15] M. Botchan,et al. Expression of enhanced levels of small RNA polymerase III transcripts encoded by the B2 repeats in simian virus 40-transformed mouse cells , 1985, Nature.
[16] P. Cohen,et al. The glycogen-binding subunit of protein phosphatase-1G from rabbit skeletal muscle. Further characterisation of its structure and glycogen-binding properties. , 1989, European journal of biochemistry.
[17] M. Mumby,et al. Distinct Roles for PP1 and PP2A in Phosphorylation of the Retinoblastoma Protein , 1999, The Journal of Biological Chemistry.
[18] David M. Livingston,et al. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element , 1989, Cell.
[19] J. Harper,et al. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. , 1997, Molecular biology of the cell.
[20] J. Bartek,et al. Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint , 1996, Molecular and cellular biology.
[21] Identification of members of the protein phosphatase 1 gene family in the rat and enhanced expression of protein phosphatase 1 alpha gene in rat hepatocellular carcinomas. , 1991, Japanese journal of cancer research : Gann.
[22] Jean Y. J. Wang,et al. Differential Regulation of Retinoblastoma Protein Function by Specific Cdk Phosphorylation Sites (*) , 1996, The Journal of Biological Chemistry.
[23] J. Nevins,et al. Identification of a cellular transcription factor involved in E1A trans-activation , 1986, Cell.
[24] R. Weinberg,et al. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[25] A. Schönthal,et al. Inhibitory phosphorylation of PP1alpha catalytic subunit during the G(1)/S transition. , 1999, The Journal of biological chemistry.
[26] J. Massagué,et al. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. , 1995, Genes & development.
[27] L. Taylor,et al. Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product , 1995, Nature.
[28] J. Nevins,et al. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[29] T. Toda,et al. The fission yeast dis2 + gene required for chromosome disjoining encodes one of two putative type 1 protein phosphatases , 1989, Cell.
[30] Kristian Helin,et al. Cell Cycle-Regulated Expression of MammalianCDC6 Is Dependent on E2F , 1998, Molecular and Cellular Biology.
[31] S. Elledge,et al. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. , 1995, Genes & development.
[32] C. Y. Wang,et al. Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. , 1993, Science.
[33] A. Yen,et al. Hypophosphorylation of the RB protein in S and G2 as well as G1 during growth arrest. , 1998, Experimental cell research.
[34] A. Yen,et al. Late dephosphorylation of the RB protein in G2 during the process of induced cell differentiation. , 1994, Experimental cell research.
[35] P. Cohen,et al. An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues , 1989, FEBS letters.
[36] T. Hunter,et al. Okadaic acid, a potent inhibitor of type 1 and type 2A protein phosphatases, activates cdc2/H1 kinase and transiently induces a premature mitosis‐like state in BHK21 cells. , 1990, The EMBO journal.
[37] N. Berndt,et al. Constitutively active protein phosphatase 1α causes Rb-dependent G1 arrest in human cancer cells , 1997, Current Biology.
[38] S. Elledge,et al. Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53 , 1995, FEBS letters.
[39] E. Wintersberger,et al. Histone Deacetylase 1 Can Repress Transcription by Binding to Sp1 , 1999, Molecular and Cellular Biology.
[40] P. Dirks,et al. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation. , 1996, Critical reviews in biochemistry and molecular biology.
[41] H. Nasheuer,et al. Human DNA polymerase alpha gene: sequences controlling expression in cycling and serum-stimulated cells , 1991, Molecular and cellular biology.
[42] N. Dyson,et al. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. , 1990, The EMBO journal.
[43] G. Hannon,et al. p21-containing cyclin kinases exist in both active and inactive states. , 1994, Genes & development.
[44] P. Greengard,et al. Cell cycle-dependent phosphorylation of mammalian protein phosphatase 1 by cdc2 kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[45] R. Weinberg,et al. Physical interaction of the retinoblastoma protein with human D cyclins , 1993, Cell.
[46] W. Lee,et al. C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[47] A. Gavin,et al. Induction of M-phase entry of prophase-blocked mouse oocytes through microinjection of okadaic acid, a specific phosphatase inhibitor. , 1991, Experimental cell research.
[48] M. Kitagawa,et al. The consensus motif for phosphorylation by cyclin D1‐Cdk4 is different from that for phosphorylation by cyclin A/E‐Cdk2. , 1996, The EMBO journal.
[49] Tony Hunter,et al. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.
[50] W. Lee,et al. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. , 1990, Science.
[51] R. Weinberg,et al. Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[52] P. J. Welch,et al. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle , 1993, Cell.
[53] W. Lee,et al. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[54] K. Münger,et al. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein , 1992, Journal of virology.
[55] P. Rigby,et al. Regulation of RNA polymerase III transcription in response to Simian virus 40 transformation. , 1990, The EMBO journal.
[56] James M. Roberts,et al. Cloning of p27 Kip1 , a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals , 1994, Cell.
[57] M. Roussel,et al. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6 , 1995, Molecular and cellular biology.
[58] A. Bielawska,et al. Phosphatidic Acid Is a Potent And Selective Inhibitor of Protein Phosphatase 1 and an Inhibitor of Ceramide-mediated Responses* , 1999, The Journal of Biological Chemistry.
[59] David M. Livingston,et al. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins , 1993, Cell.
[60] Phang-lang Chen,et al. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation , 1989, Cell.
[61] P. Cohen,et al. The myosin-bound form of protein phosphatase 1 (PP-1M) is the enzyme that dephosphorylates native myosin in skeletal and cardiac muscles , 1988 .
[62] N. Krucher,et al. Hypoxia-induced pRB hypophosphorylation results from downregulation of CDK and upregulation of PP1 activities , 1998, Oncogene.
[63] K. Münger,et al. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. , 1989, The EMBO journal.
[64] M. Vidal,et al. The retinoblastoma protein binds to a family of E2F transcription factors , 1993, Molecular and cellular biology.
[65] J. Pouysségur,et al. Cyclin D1 Expression Is Regulated Positively by the p42/p44MAPK and Negatively by the p38/HOGMAPK Pathway* , 1996, The Journal of Biological Chemistry.
[66] T. L. McGee,et al. Structure and partial genomic sequence of the human retinoblastoma susceptibility gene. , 1989, Gene.
[67] V. Pant,et al. The molecular and functional characterization of E2F-5 transcription factor. , 1998, Biochemical and biophysical research communications.
[68] P. Rigby,et al. Activation of mouse genes in transformed cells , 1983, Cell.
[69] X. Graña,et al. The p130 pocket protein: keeping order at cell cycle exit/re-entrance transitions. , 1998, Frontiers in bioscience : a journal and virtual library.
[70] P. Whyte,et al. Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes , 1997, Oncogene.
[71] P. Cohen,et al. The protein phosphatases involved in cellular regulation , 1984 .
[72] R. Weinberg,et al. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. , 1996, Oncogene.
[73] L. Obeid,et al. Cell-cycle-dependent changes in ceramide levels preceding retinoblastoma protein dephosphorylation in G2/M. , 1998, The Biochemical journal.
[74] B. Henglein,et al. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E 2 F site , 2022 .
[75] X. Graña,et al. G1 cyclin/CDK-independent phosphorylation and accumulation of p130 during the transition from G1 to G0 lead to its association with E2F-4. , 1996, Oncogene.
[76] J. Harbour,et al. Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1 , 1999, Cell.
[77] J. Bartek,et al. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity , 1995, Molecular and cellular biology.
[78] V. Richon,et al. Regulation and Expression of Retinoblastoma Proteins p107 and p130 during 3T3-L1 Adipocyte Differentiation* , 1997, The Journal of Biological Chemistry.
[79] S. Jackson,et al. Repression of RNA polymerase III transcription by the retinoblastoma protein , 1996, Nature.
[80] P. Robbins,et al. The human retinoblastoma susceptibility gene promoter is positively autoregulated by its own product. , 1994, The Journal of biological chemistry.
[81] D. Kimelman,et al. E1a regions of the human adenoviruses and of the highly oncogenic simian adenovirus 7 are closely related , 1985, Journal of virology.
[82] S. Mittnacht,et al. Binding of select forms of pRB to protein phosphatase type 1 independent of catalytic activity , 1999, Oncogene.
[83] J. Bartek,et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 , 1995, Nature.
[84] J. Nevins,et al. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals , 1997, Molecular and cellular biology.
[85] R. White,et al. Regulation of RNA polymerases I and III by the retinoblastoma protein: a mechanism for growth control? , 1997, Trends in biochemical sciences.
[86] L. Hengst,et al. Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1). , 1998, Genes & development.
[87] D. Beach,et al. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. , 1993, Genes & development.
[88] M. Ewen,et al. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. , 1993, Genes & development.
[89] S. Elledge,et al. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. , 1993, Genes & development.
[90] D. Nelson,et al. High Molecular Weight Protein Phosphatase Type 1 Dephosphorylates the Retinoblastoma Protein* , 1997, The Journal of Biological Chemistry.
[91] P. Cohen,et al. Purification of the hepatic glycogen‐associated form of protein phosphatase‐1 by microcystin‐Sepharose affinity chromatography , 1995, FEBS letters.
[92] T. Sugimura,et al. Protein phosphatase 1γ2 is associated with nuclei of meiotic cells in rat testis , 1993 .
[93] M. Ewen,et al. An N-Terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110 Rb and a second cellular protein, p120 , 1989, Cell.
[94] A. Schönthal,et al. Inhibitory Phosphorylation of PP1α Catalytic Subunit during the G1/S Transition* , 1999, The Journal of Biological Chemistry.
[95] X. Graña,et al. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. , 1995, Oncogene.
[96] D. Nelson,et al. Control and activity of type-1 serine/threonine protein phosphatase during the cell cycle. , 1995, Seminars in cancer biology.
[97] T. L. McGee,et al. Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene , 1991, Nature.
[98] P. Greengard,et al. Isolation and Characterization of PNUTS, a Putative Protein Phosphatase 1 Nuclear Targeting Subunit* , 1998, The Journal of Biological Chemistry.
[99] D. Livingston,et al. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T , 1990, Cell.
[100] A. Takai,et al. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. , 1988, The Biochemical journal.
[101] Stephen H. Friend,et al. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product , 1988, Nature.
[102] W. Sellers,et al. Interaction between the retinoblastoma protein and the oncoprotein MDM2 , 1995, Nature.
[103] D. Riley,et al. The retinoblastoma protein: more than a tumor suppressor. , 1994, Annual review of cell biology.
[104] H. C. Smith,et al. Hypoxic stress induces reversible hypophosphorylation of pRB and reduction in cyclin A abundance independent of cell cycle progression. , 1993, Oncogene.
[105] R. Bernards,et al. Functional interaction between a novel protein phosphatase 2A regulatory subunit, PR59, and the retinoblastoma-related p107 protein , 1999, Oncogene.
[106] Y. Hannun,et al. Retinoblastoma protein dephosphorylation induced by D-erythro-sphingosine. , 1992, The Journal of biological chemistry.
[107] Wen-Hwa Lee,et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.
[108] D. Livingston,et al. Specific enzymatic dephosphorylation of the retinoblastoma protein , 1993, Molecular and cellular biology.
[109] Y. Hannun,et al. Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[110] K. Yokoyama,et al. The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator , 1994, Molecular and cellular biology.
[111] P. Cohen,et al. Protein phosphatases: properties and role in cellular regulation. , 1983, Science.
[112] R. Kerkhoven,et al. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. , 1995, Genes & development.
[113] M. Kasten,et al. The RB family of cell cycle regulatory factors. , 1998, Journal of cellular biochemistry. Supplement.
[114] L. Leffet,et al. Analysis of site-specific phosphorylation of the retinoblastoma protein during cell cycle progression. , 1999, Experimental Cell Research.
[115] M. Bollen,et al. The isolation of novel inhibitory polypeptides of protein phosphatase 1 from bovine thymus nuclei. , 1992, The Journal of biological chemistry.
[116] M. Ewen,et al. Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product , 1990, Molecular and cellular biology.
[117] R. Beijersbergen,et al. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. , 1996, Biochimica et biophysica acta.
[118] A. Yen,et al. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. , 1989, Science.
[119] W. Lee,et al. Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. , 1990, The EMBO journal.
[120] M. Skolnick,et al. A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.
[121] D. Mann,et al. Protein serine/threonine phosphatases; an expanding family , 1990, FEBS letters.
[122] W. Lee,et al. Structure of the human retinoblastoma gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[123] X. Graña,et al. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth , 1998, Oncogene.
[124] M. Skolnick,et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus , 1994, Nature Genetics.
[125] R. Bernards,et al. E2F: a nodal point in cell cycle regulation. , 1997, Biochimica et biophysica acta.
[126] A. Schulze,et al. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[127] D. Johnson,et al. Role of E2F in cell cycle control and cancer. , 1998, Frontiers in bioscience : a journal and virtual library.
[128] F. Kaye,et al. A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[129] J. Nevins,et al. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes , 1995, Molecular and cellular biology.
[130] K. Münger,et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.
[131] K. Moberg,et al. E2F activity is regulated by cell cycle-dependent changes in subcellular localization , 1997, Molecular and cellular biology.
[132] L. Zhu,et al. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. , 1994, Genes & development.
[133] Marc Vidal,et al. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F , 1992, Cell.
[134] F. Huang,et al. Separation and characterization of two phosphorylase phosphatase inhibitors from rabbit skeletal muscle. , 1976, European journal of biochemistry.
[135] P. Farnham,et al. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. , 1994, Genes & development.
[136] W. Sellers,et al. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter , 1994, Molecular and cellular biology.
[137] E. Moran,et al. A region of SV40 large T antigen can substitute for a transforming domain of the adenovirus E1A products , 1988, Nature.
[138] A. Schönthal,et al. Autoregulation of Protein Phosphatase Type 2A Expression* , 1998, The Journal of Biological Chemistry.
[139] E. Harlow,et al. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle , 1989, Cell.
[140] Y. Taya,et al. Inactivation of oncoprotein binding by a single Cys706‐to‐Tyr substitution in the retinoblastoma protein , 1994, FEBS letters.
[141] K. Helin,et al. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription , 1998, Oncogene.
[142] Robert A. Weinberg,et al. Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes , 1998, Molecular and Cellular Biology.
[143] J. Bartek,et al. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression , 1996, Molecular and cellular biology.
[144] D. Rappolee,et al. A single Cys706 to Phe substitution in the retinoblastoma protein causes the loss of binding to SV40 T antigen. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[145] T. Sugimura,et al. Identification of Members of the Protein Phosphatase 1 Gene Family in the Rat and Enhanced Expression of Protein Phosphatase 1α Gene in Rat Hepatocellular Carcinomas , 1990, Japanese journal of cancer research : Gann.
[146] B. Gallie,et al. Cumulative Effect of Phosphorylation of pRB on Regulation of E2F Activity , 1999, Molecular and Cellular Biology.
[147] S. Dalton,et al. Cell cycle regulation of the human cdc2 gene. , 1992, The EMBO journal.
[148] R. Bernards,et al. Rapid dephosphorylation of p107 following UV irradiation , 1999, Oncogene.
[149] Hua,et al. Identification of , 2000, Journal of insect physiology.
[150] D. Glover,et al. One of the protein phosphatase 1 isoenzymes in Drosophila is essential for mitosis , 1990, Cell.
[151] D. Brautigan,et al. Protein phosphatase type 1 in mammalian cell mitosis: chromosomal localization and involvement in mitotic exit , 1992, The Journal of cell biology.
[152] David Beach,et al. p21 is a universal inhibitor of cyclin kinases , 1993, Nature.
[153] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[154] L. Magnaghi-Jaulin,et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase , 1998, Nature.
[155] P. Farnham,et al. A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter , 1993, Molecular and cellular biology.
[156] J. Blanchard,et al. Cyclin A expression is under negative transcriptional control during the cell cycle , 1996, Molecular and cellular biology.
[157] N. Krucher,et al. Molecular analysis of selected cell cycle regulatory proteins during aerobic and hypoxic maintenance of human ovarian carcinoma cells , 1999, British Journal of Cancer.
[158] Sibylle Mittnacht,et al. Differential Phosphorylation of the Retinoblastoma Protein by G1/S Cyclin-dependent Kinases* , 1997, The Journal of Biological Chemistry.
[159] J. Herman,et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.
[160] P. Cohen,et al. A myofibrillar protein phosphatase from rabbit skeletal muscle contains the beta isoform of protein phosphatase-1 complexed to a regulatory subunit which greatly enhances the dephosphorylation of myosin. , 1992, European journal of biochemistry.
[161] P. Cohen,et al. Okadaic acid: a new probe for the study of cellular regulation. , 1990, Trends in biochemical sciences.
[162] P. Cohen,et al. Identification of a third form of protein phosphatase 1 in rabbit skeletal muscle that is associated with myosin. , 1988, Biochimica et biophysica acta.
[163] J. Doonan,et al. The bimG gene of Aspergillus nidulans, required for completion of anaphase, encodes a homolog of mammalian phosphoprotein phosphatase 1 , 1989, Cell.
[164] P. Greengard,et al. Cell cycle-dependent phosphorylation of mammalian protein phosphatase 1 by cdc 2 kinase , 1997 .
[165] Joseph R. Nevins,et al. The E2F transcription factor is a cellular target for the RB protein , 1991, Cell.
[166] J. Nevins,et al. Expression of transcription factor E2F1 induces quiescent cells to enter S phase , 1993, Nature.
[167] J. Herman,et al. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. , 1998, Cancer research.
[168] W. Clark,et al. Germline p16 mutations in familial melanoma , 1994, Nature Genetics.
[169] P. Cohen,et al. The protein phosphatases involved in cellular regulation. 6. Measurement of type-1 and type-2 protein phosphatases in extracts of mammalian tissues; an assessment of their physiological roles. , 1983, European journal of biochemistry.